Showing results (1081-1090 of 2,005) with videos related to
Sort By:
Pageof 201
Journal of Clinical Lipidology|February 5, 2011
Effect of ezetimibe/simvastatin vs atorvastatin on lowering levels of LDL-C and non-HDL-C, ApoB, and hs-CRP in patients with type 2 diabetesRuth S Weinstock, Ronald B Goldberg, John R Guyton, et al.Journal of Clinical Lipidology|February 5, 2011
Clinical commentary: Reaching new targets in monotherapy and combination therapyRyan C NealJournal of Clinical Lipidology|February 5, 2011
Dietary agents that target gastrointestinal and hepatic handling of bile acids and cholesterolPeter J H JonesJournal of Clinical Lipidology|February 5, 2011
Male hypogonadism: The unrecognized cardiovascular risk factorMatthew Potenza, Mona ShimshiJournal of Clinical Lipidology|February 5, 2011
Elevated atherogenic lipoproteins in childhood: Risk, prevention, and treatmentBrian W McCrindle, Cedric ManlhiotJournal of Clinical Lipidology|February 5, 2011
Clinical and laboratory assessment of cardiovascular risk in children: Guidelines for screening, evaluation, and treatmentPeter O KwiterovichJournal of Clinical Lipidology|February 5, 2011
Ezetimibe/simvastatin compared with atorvastatin or rosuvastatin in lowering to specified levels both LDL-C and each of five other emerging risk factors for coronary heart disease: Non-HDL-cholesterol, TC/HDL-C, apolipoprotein B, apo-B/apo-A-I, or C-reactive proteinMichael H Davidson, Nicola Abate, Christie M Ballantyne, et al.Journal of Clinical Lipidology|February 5, 2011
Flushing and other dermatologic adverse events associated with extended-release niacin therapyJohn R Guyton, Phillip D SimmonsJournal of Clinical Lipidology|February 5, 2011
Effects of prescription omega-3-acid ethyl esters on lipoprotein particle concentrations, apolipoproteins AI and CIII, and lipoprotein-associated phospholipase A(2) mass in statin-treated subjects with hypertriglyceridemiaMichael H Davidson, Kevin C Maki, Harold Bays, et al.Journal of Clinical Lipidology|January 26, 2011
Patient tolerance regarding different low-density lipoprotein apheresis columns: frequent minor side effects and high patient satisfactionAnders Hovland, Randolf Hardersen, Terje Enebakk, et al.Pageof 201